IO Biotech, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€390.28K - Gross profit
-€201.60K - SG&A expenses
€21.41M - R&D expenses
€64.06M - EBITDA
-€87.21M - D&A
€566.90K - EBIT
-€85.47M - Interest expenses
€217.97K - EBT
-€88.80M - Tax expenses
€790.90K - Net income
-€89.59M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€5.39M - Changes in working capital
€8.17M - Operating cash flow
-€71.79M - Capex
€64.62K - Other investing cash flow
€0.00 - Net investing cash flow
-€64.62K - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€9.90M - Other financing cash flow
€0.00 - Net financing cash flow
€9.90M - Foreign exchange effects
-€604.81K - Net change in cash
-€62.56M - Cash at end of period
€24.47M - Free cash flow
-€71.72M
Balance sheet
- Cash and cash equivalents
€24.24M - Cash and short-term investments
€24.24M - Total receivables
€983.03K - Inventory
€0.00 - Other current assets
€8.36M - Total current assets
€33.58M - Property, plant & equipment
€1.79M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€230.90K - Other non-current assets
€865.86K - Total non-current assets
€2.88M - Total assets
€36.47M - Accounts payable
€4.77M - Short-term debt
€661.67K - Other current liabilities
€11.71M - Total current liabilities
€17.14M - Long-term debt
€6.54M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€11.41M - Total non-current liabilities
€17.95M - Total liabilities
€35.09M - Common stock
€56.86K - Retained earnings
-€351.47M - Other equity
-€5.87M - Total equity
€1.37M - Total liabilities and shareholders' equity
€36.47M
Company information
- Market capitalization
€80.92M - Employees
80 - Enterprise Value
€63.50M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-6,531.8% Much worse than peer group: -7.4% - ROA
-
-245.7% Much better than peer group: -6,971.5% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-88.8% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.12M